TEACHERS ADVISORS, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$3,318,000
-34.4%
347,822
-21.0%
0.00%
-42.9%
Q4 2018$5,057,000
-85.1%
440,475
-78.0%
0.01%
-65.0%
Q3 2018$33,916,000
+157.6%
2,000,970
+115.8%
0.02%
+25.0%
Q2 2018$13,167,000
-23.7%
927,221
+2.0%
0.02%
-27.3%
Q1 2018$17,267,000
+11.3%
908,787
-3.9%
0.02%
+10.0%
Q4 2017$15,516,000
+26.5%
946,128
+15.8%
0.02%
+17.6%
Q3 2017$12,261,000
+692.6%
817,385
+365.0%
0.02%
+750.0%
Q2 2017$1,547,000
+64.6%
175,797
-2.8%
0.00%
+100.0%
Q1 2017$940,000
+87.3%
180,858
+9.8%
0.00%0.0%
Q4 2016$502,000
-30.9%
164,728
+4.9%
0.00%0.0%
Q3 2016$727,000
-20.0%
157,0350.0%0.00%
-50.0%
Q2 2016$909,000
-3.9%
157,035
+0.4%
0.00%0.0%
Q1 2016$946,000
-31.6%
156,425
+3.3%
0.00%
-33.3%
Q4 2015$1,383,000
+61.9%
151,4330.0%0.00%
+50.0%
Q3 2015$854,000
-81.1%
151,433
-62.9%
0.00%
-75.0%
Q2 2015$4,528,000
-28.5%
408,252
+1.2%
0.01%
-33.3%
Q1 2015$6,329,000
+5.6%
403,607
+2.5%
0.01%
+9.1%
Q4 2014$5,992,000
+284.1%
393,937
+172.4%
0.01%
+266.7%
Q3 2014$1,560,000
-23.8%
144,621
+7.9%
0.00%
-25.0%
Q2 2014$2,047,000
-12.6%
134,035
+3.5%
0.00%
-20.0%
Q1 2014$2,341,000
+60.8%
129,456
+23.5%
0.01%
+66.7%
Q4 2013$1,456,000
+42.7%
104,834
+7.7%
0.00%0.0%
Q3 2013$1,020,000
+37.7%
97,354
+2.6%
0.00%
+50.0%
Q2 2013$741,00094,8540.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders